Market's view on Haydale
Published on April 2024
- A stock watcher noted the increase in trading activity and has invested more due to a volume spike.
- Positive advancements are highlighted as studies into the human health effects of graphene have shown promising results.
- Another watcher invested in the company following decent interim results, anticipating a recovery.
- Haydale reported a 38% increase in group revenues in their interim results, with a successful fundraising event and a cost savings plan underway.
- Collaboration with Petroliam Nasional Berhad is strengthened through mutual visits, enhancing Haydale’s business relationship.
- Concerns were expressed about the company’s future financial stability despite a recent fundraise, as further equity funding might be needed which could dilute shareholder value.
- Some stock watchers are optimistic about management’s positive outlook and progress in key markets.
- Interest from Octopus Investments in taking a 23% stake is seen as a positive sign by some watchers.
- Criticism on the company’s performance, with fears that without a significant increase in sales, further fundraising will be necessary.
- The collaboration with Saint-Gobain Boron Nitride on functionalized powders is seen as a positive development by some.
- Discontent with the decision to split stocks into deferred shares, which are expected to be worthless and eventually cancelled.
- A stock watcher expressed opposition to all proposed resolutions in the recent voting forms.
- The company’s ability to raise £5 million is questioned by some, with calls for the board to be sacked for poor management.
- Skepticism is shared regarding the sustainability of the company’s financial strategy, suggesting a need for major restructuring.